Gabapentin
Product Images NDC 50436-5550

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50436-5550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

A text panel displaying a formula to calculate creatinine clearance (CLCr). The formula involves age, weight, serum creatinine, and a factor for female patients, presented within brackets and multiplication symbols.*

FDA Label Image

Image 2

FDA Label Image

Image 3

FDA Label Image

Image 4

FDA Label Image

Image 5

Chemical structure of gabapentin showing a cyclohexane ring bonded to amino and carboxymethyl groups.*

FDA Label Image

Image 6

A line graph comparing mean pain scores over an 8-week period between placebo and Gabapentin 3600 mg/day groups. The x-axis represents weeks including a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores, with Gabapentin group scores decreasing over time compared to the stable placebo group.*

FDA Label Image

Image 7

A line graph illustrating mean pain scores over a 7-week period, comparing placebo with Gabapentin doses of 1800 mg/day and 2400 mg/day. The x-axis represents weeks from baseline to week 7, and the y-axis shows mean pain scores ranging from 0 to 10. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Image 8

A bar chart comparing percentage values across two studies for a drug labeled GBP (Gabapentin) at different doses versus placebo (PBO). Study 1 shows 12% for placebo and 29% for GBP 3600 dose. Study 2 shows 14% for placebo, with 32% and 34% for GBP 1800 and GBP 2400 doses respectively. Statistical significance is noted with p values less than 0.01 and 0.001.*

FDA Label Image

Image 9

A scatter plot depicting difference percentages by daily dose in milligrams for Gabapentin across three studies labeled a, b, and c. The x-axis represents daily dose from 600 to 1800 mg, and the y-axis shows difference percentages from 2 to 22%. Points for each study are indicated by different shapes and colors as in the legend.*

FDA Label Image

Label Image (Lbl504365550)

Gabapentin 100 mg capsules label from Unit Dose Services. The label includes NDC 50436-5550, manufacturing information from Watson Pharma Pvt Ltd, Goa, India, and the quantity of 30 capsules. It also displays storage instructions and a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.